Not everyone wants IPV; opposition gears up

Article Abstract:

The proposed use of an inactivated poliovirus vaccine (IPV) is being criticized by some health care groups and physicians. The U.S. childhood immunization policy may shift to using IPV instead of the the live oral poliovirus vaccine (OPV) because of several cases of paralytic polio associated with OPV. The change may impact immunization efforts because of increased cost and additional visits associated with IPV. Another drawback is that the use of IPV requires injection, while the live virus is swallowed. There are also doubts about IPV being any less likely to cause paralysis than OPV.

Author: Marwick, Charles
Social aspects, Poliomyelitis vaccine, Poliovirus vaccines

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Jane E. Henney, MD, Is New FDA Commissioner

Article Abstract:

Jane E. Henney is the first woman to be appointed as FDA Commissioner. Henney was a deputy commissioner at the FDA between 1992 and 1994 and also served in academic positions at the University of New Mexico and the University of Kansas City School of Medicine. She received her MD degree from Indiana University School of Medicine.

Author: Marwick, Charles
United States. Food and Drug Administration, Henney, Jane E.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.